.png)
Loading...
Email
Linkedin
Facebook
X
Copy Link
TranscriptThe price of bitcoin recently hit $88,000, yet it remains a speculative currency with few present-day commercial uses. Why is bitcoin so compelling to certain investors, and what is its potential for everyday use?
Join Steve Odland and guest Hollis Hart, former president of international franchise management at Citi and a senior fellow at The Conference Board's ESF Center, to learn why there’s a finite amount of bitcoin available, the differences between bitcoin and other cryptocurrencies, and how governments have responded to this new technology.
(00:22) Introduction to Cryptocurrencies
(02:15) Bitcoin's Mechanics and Decentralization
(05:26) Bitcoin's Supply and Market Dynamics
(07:13) Commercial Use and Speculation
(15:48) Ethereum and Other Cryptocurrencies
(20:30) Blockchain Technology and Its Potential
(27:25) Regulatory Concerns and Conclusion
C-Suite Perspectives is a series hosted by our President & CEO, Steve Odland. This weekly conversation takes an objective, data-driven look at a range of business topics aimed at executives. Listeners will come away with what The Conference Board does best: Trusted Insights for What’s Ahead®.
C-Suite Perspectives provides unique insights for C-Suite executives on timely topics that matter most to businesses as selected by The Conference Board. If you would like to suggest a guest for the podcast series, please email csuite.perspectives@conference-board.org. Note: As a non-profit organization under 501(c)(3) of the IRS Code, The Conference Board cannot promote or offer marketing opportunities to for-profit entities.
C-Suite Perspectives / 04 Aug 2025
More C-Suite leaders view their boards as effective in 2025, but numerous challenges remain, including keeping up with AI.
C-Suite Perspectives / 29 Jul 2025
We break down the latest data from The Conference Board Consumer Confidence Index®, released today.
C-Suite Perspectives / 28 Jul 2025
Learn how Clorox invested in technological innovation so it could continue delivering superior consumer experiences.
C-Suite Perspectives / 21 Jul 2025
2025 is half over. What issues should human capital leaders focus on during the rest of the year?
C-Suite Perspectives / 14 Jul 2025
Learn why culture and constant innovation are essential to developing life-changing biopharma treatments.
C-Suite Perspectives / 07 Jul 2025
We've just passed the midway point of 2025 -- what are the top 10 priorities for chief marketing officers (CMOs) for the rest of the year?
